Volume 119, Issue 1 , Pages 184-191, January 2007
Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trial
Background
Despite preliminary evidence, the role of probiotics in allergy prevention is unclear.
Objective
To determine whether early probiotic supplementation prevents allergic disease in high-risk infants.
Methods
Newborns of women with allergy (n = 231) received either Lactobacillus acidophilus (LAVRI-A1) or placebo daily for the first 6 months of life. Children were assessed for atopic dermatitis (AD) and other symptoms at 6 and 12 months and had allergen skin prick tests (SPT) at 12 months of age.
Results
A total of 178 infants completed the supplementation period. Those in the probiotic group showed significantly higher rates of Lactobacillus colonization (P = .039). At 6 months, AD rates were similar in the probiotic (n = 23/89; 25.8%) and placebo (n = 20/88; 22.7%) groups (P = .629). There was also no difference at 12 months, although the proportion of children with SPT+AD was significantly higher in the probiotic group (P = .045). At 12 months, the rate of sensitization was significantly higher in the probiotic group (P = .030). The presence of culturable Lactobacilli or Bifidobacterium in stools in the first month of life was not associated with the risk of subsequent sensitization or disease; however, the presence of Lactobacillus at 6 months of age was associated with increased risk of subsequent cow's milk sensitization (P = .012).
Conclusion
Early probiotic supplementation with L acidophilus did not reduce the risk of AD in high-risk infants and was associated with increased allergen sensitization in infants receiving supplements. The long-term significance of the increased rate of sensitization needs to be investigated in further studies.
Clinical implications
These findings challenge the role of probiotics in allergy prevention.
Key words: Probiotic, infant, atopic dermatitis, sensitization, allergy prevention
Abbreviations used: AD, Atopic dermatitis, OR, Odds ratio, SPT, Skin prick test
Supported jointly by the National Health and Medical Research Council of Australia and Probiomics as an industry partner. The study and all of the analyses were conducted independently of the commercial entity.Disclosure of potential conflict of interest: A. L. Taylor, J. A. Dunstan, and S. L. Prescott have received grant support from the National Health and Medical Research Council of Australia and Probiomics.
PII: S0091-6749(06)01798-2
doi:10.1016/j.jaci.2006.08.036
© 2007 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 119, Issue 1 , Pages 184-191, January 2007
